| Bioactivity | Obafistat is a potent aldo-keto reductase AKR1C3 inhibitor with an IC50 of 1.2 nM for human AKR1C3 (patent WO2017202817A1, example 4)[1]. |
| Name | Obafistat |
| CAS | 2160582-57-8 |
| Formula | C15H16FN5O3S |
| Molar Mass | 365.38 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
| Reference | [1]. Marcus Koppitz, et al. [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl] (1h-1,2,3-triazol-4-yl)methanones. WO2017202817A1. |
Obafistat
CAS: 2160582-57-8 F: C15H16FN5O3S W: 365.38
Obafistat is a potent aldo-keto reductase AKR1C3 inhibitor with an IC50 of 1.2 nM for human AKR1C3 (patent WO2017202817A
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.